Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers.

IF 3.4 2区 医学 Q2 ONCOLOGY
Ying Liu, Wei He, Qi Wu, Jia-Fu Ji, Lin Shen, Chun-Yi Hao, Rui-Ping Xu, Ke-Neng Chen, Nan Wu, Chang-Qi Cao, Ying Hu, Li-Xin Zhang, Huan-Yu Chen, Zhe Hu, Ya-Qi Pan, Wen-Qing Yuan, Jing-Jing Li, Bin Dong, Meng-Fei Liu, Zhen Liu, Fang-Fang Liu, Hong Cai, Zhong-Hu He, Yang Ke
{"title":"Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers.","authors":"Ying Liu, Wei He, Qi Wu, Jia-Fu Ji, Lin Shen, Chun-Yi Hao, Rui-Ping Xu, Ke-Neng Chen, Nan Wu, Chang-Qi Cao, Ying Hu, Li-Xin Zhang, Huan-Yu Chen, Zhe Hu, Ya-Qi Pan, Wen-Qing Yuan, Jing-Jing Li, Bin Dong, Meng-Fei Liu, Zhen Liu, Fang-Fang Liu, Hong Cai, Zhong-Hu He, Yang Ke","doi":"10.1186/s12885-025-14845-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patient-derived xenografts (PDX) models have been regarded as an important tool for preclinical research. The aim of this study was to establish a Chinese PDX library from gastrointestinal cancers, especially esophageal squamous cell carcinoma (ESCC), esophagogastric junction adenocarcinoma (EGJAC), and gastric adenocarcinoma (GAC).</p><p><strong>Methods: </strong>1001 surgical tissues or endoscopic biopsy tissues of gastrointestinal cancers were subcutaneously implanted into NOD/SCID mice between January 2013 and August 2015. Engraftment rates, latency period of xenograft formation, patients' clinicopathological characteristics and survival associated with xenografts for ESCC, EGJAC and GAC were assessed.</p><p><strong>Results: </strong>208 PDX models were established (20.8%, 208/1001), among which 82 were from ESCC (21.2%, 82/386), 31 from EGJAC (16.9%, 31/183), and 29 from GAC (10.9%, 29/266). The average latency period of xenograft formation of ESCC, EGJAC, and GAC was 76.2, 90.5, and 85.2 days, respectively, for the first passage, and decreased to 52.5, 54.8, and 52.6 days, respectively for the second passage. For ESCC, gender, specimen type and differentiation were associated with engraftment; and for GAC, the factors associated with engraftment were age, specimen type, differentiation, and Lauren classification. The median follow-up of patients with ESCC, EGJAC and GAC was 46, 64 and 64 months, respectively. For GAC, the survival time of patients from whom the tumor tissues achieved successful engraftment was significantly shorter than that without xenograft formation.</p><p><strong>Conclusions: </strong>We established a Chinese PDX library from gastrointestinal cancers, especially ESCC, a characteristic tumor type in China, providing a platform for drug development and individualized therapy.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"1508"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495745/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-14845-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patient-derived xenografts (PDX) models have been regarded as an important tool for preclinical research. The aim of this study was to establish a Chinese PDX library from gastrointestinal cancers, especially esophageal squamous cell carcinoma (ESCC), esophagogastric junction adenocarcinoma (EGJAC), and gastric adenocarcinoma (GAC).

Methods: 1001 surgical tissues or endoscopic biopsy tissues of gastrointestinal cancers were subcutaneously implanted into NOD/SCID mice between January 2013 and August 2015. Engraftment rates, latency period of xenograft formation, patients' clinicopathological characteristics and survival associated with xenografts for ESCC, EGJAC and GAC were assessed.

Results: 208 PDX models were established (20.8%, 208/1001), among which 82 were from ESCC (21.2%, 82/386), 31 from EGJAC (16.9%, 31/183), and 29 from GAC (10.9%, 29/266). The average latency period of xenograft formation of ESCC, EGJAC, and GAC was 76.2, 90.5, and 85.2 days, respectively, for the first passage, and decreased to 52.5, 54.8, and 52.6 days, respectively for the second passage. For ESCC, gender, specimen type and differentiation were associated with engraftment; and for GAC, the factors associated with engraftment were age, specimen type, differentiation, and Lauren classification. The median follow-up of patients with ESCC, EGJAC and GAC was 46, 64 and 64 months, respectively. For GAC, the survival time of patients from whom the tumor tissues achieved successful engraftment was significantly shorter than that without xenograft formation.

Conclusions: We established a Chinese PDX library from gastrointestinal cancers, especially ESCC, a characteristic tumor type in China, providing a platform for drug development and individualized therapy.

建立中国胃肠道肿瘤患者来源异种移植物文库。
背景:患者来源的异种移植物(PDX)模型已被视为临床前研究的重要工具。本研究旨在建立中国胃肠道肿瘤,特别是食管鳞状细胞癌(ESCC)、食管胃交界腺癌(EGJAC)和胃腺癌(GAC)的PDX文库。方法:2013年1月至2015年8月,将1001例胃肠道肿瘤手术组织或内镜活检组织皮下植入NOD/SCID小鼠。评估ESCC、EGJAC和GAC的移植率、异种移植物形成潜伏期、患者临床病理特征和与异种移植物相关的生存率。结果:共建立PDX模型208只(20.8%,208/1001),其中ESCC模型82只(21.2%,82/386),EGJAC模型31只(16.9%,31/183),GAC模型29只(10.9%,29/266)。ESCC、EGJAC和GAC异种移植物形成的平均潜伏期,第一传代分别为76.2、90.5和85.2天,第二传代分别降至52.5、54.8和52.6天。对于ESCC,性别、标本类型和分化与着床有关;对于GAC,与移植相关的因素是年龄、标本类型、分化和Lauren分类。ESCC、EGJAC和GAC患者的中位随访时间分别为46个月、64个月和64个月。对于GAC,成功植入肿瘤组织的患者的生存时间明显短于未形成异种移植物的患者。结论:我们建立了中国胃肠道肿瘤,特别是ESCC的PDX文库,为药物开发和个体化治疗提供了平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信